The F1148 hydrophobic lock: A critical determinant of SARS-CoV-2 spike protein-mediated membrane fusion via the 3H/CH cavity.

The F1148 hydrophobic lock: A critical determinant of SARS-CoV-2 spike protein-mediated membrane fusion via the 3H/CH cavity.

Publication date: Sep 19, 2025

The S2 subunit of the coronavirus Spike protein undergoes extensive conformational refolding to drive membrane fusion during viral entry. Although the HR1/HR2 six-helix bundle (6-HB) is recognized as the core mediator of fusion, the molecular driving force governing its formation remains poorly elucidated. Here, through systematic mutagenesis of the AlphaFold-predicted stem helix (SH) region in S2, followed by analysis of the resulting SC2-VLP entry phenotypes, we identified key amino acid residues within conserved helices that are present in both prefusion and postfusion Spike conformations. These elements, which we term postfusion-preserved helices (PFPHs), were found to be critical for SC2-VLP entry. Structural analysis revealed a “hydrolock” interaction between F1148 in PFPH-1 and a conserved cavity formed by 3H (I742, C749)/CH (I993, L996, I997). Deep mutational scanning demonstrated that only hydrophobic residues at F1148 were functionally viable and essential for membrane fusion, underscoring the critical role of a hydrophobic lock (“hydrolock”) interaction between F1148 and the 3H/CH cavity in membrane fusion. Furthermore, HA-replacement mutagenesis and anti-HA neutralization assays showed that significant neutralization activity was restricted to HA insertions proximal to PFPH-1, selectively inhibiting membrane fusion without affecting receptor binding. Notably, the 3H/CH cavity remains structurally stable across Spike conformations, being sequentially occupied by prefusion-L977, intermediate-F782, and postfusion-F1148. We propose a model wherein hydrolock interactions drive S2 refolding and fusion by displacing intermediate interactions. This study provides mechanistic insights into Spike dynamics and highlights hydrolock interactions as a promising target for broad-spectrum antiviral strategies.

Open Access PDF

Concepts Keywords
Antiviral 3h
Coronavirus Cavity
F1148 Ch
Hydrophobic Critical
Postfusion Drive
Entry
Fusion
Hydrolock
Hydrophobic
Interactions
Lock
Membrane
Postfusion
Refolding
Spike

Semantics

Type Source Name
disease IDO role
disease IDO protein
disease IDO history
disease IDO process
disease MESH Infection
disease MESH middle east respiratory syndrome
pathway REACTOME Translation
disease IDO replication
pathway KEGG Virion
disease MESH sid
disease IDO host
pathway REACTOME Reproduction
drug DRUGBANK Amino acids
disease IDO infectivity
drug DRUGBANK L-Alanine
disease IDO assay
disease IDO site
drug DRUGBANK Alpha-Linolenic Acid
disease IDO cell
drug DRUGBANK Methylergometrine
drug DRUGBANK L-Cysteine
drug DRUGBANK Streptomycin
drug DRUGBANK Myricetin
pathway REACTOME Digestion
disease IDO production
disease IDO reagent
drug DRUGBANK Medical air
drug DRUGBANK Tromethamine
drug DRUGBANK Sodium lauryl sulfate
drug DRUGBANK Glycerin
drug DRUGBANK Trypsin
drug DRUGBANK Aspartame
drug DRUGBANK Coenzyme M
drug DRUGBANK Proline

Original Article

(Visited 4 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *